2020年7月14日 · Conclusions: The results of this study show that cinepazide maleate injection is superior to placebo in improving neurological function and activities of daily living, reducing …

Cinepazide maleate is a piperazine derivative that acts as a weak calcium channel blocker and has been shown to reduce disability following acute ischemic stroke [7].

2016年10月20日 · Generic Name Cinepazide DrugBank Accession Number DB12123 Background Cinepazide has been used in trials studying the treatment of Ischemic Stroke. …

CINEPAZIDE is a small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1980 and is indicated for cardiovascular disease and …

Cinepazide Maleate | C26H35N3O9 | CID 5282458 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, …

2024年6月14日 · Cinepazide Maleate operates primarily through its action on the smooth muscle cells lining the blood vessels. Its primary mechanism of action involves the inhibition of …

2021年10月28日 · Cinepazide maleate is a calcium channel blocker to inhibit Ca 2+ influx, relax the vascular smooth muscle, and dilate coronary arteries. In clinical studies, animal …

Bibliographic details: Yi ZM, Liu F, Zhai SD. Cinepazide maleate injection for cerebral infarction: a systematic review. Chinese Journal of Evidence-Based Medicine 2010; 10 (9): 1079-1084.

Our previous study showed that cinepazide maleate (CM) was as effective and safe as mildronate in the treatment of acute ischemic stroke in a randomized, double-blind, active-controlled …

Cinepazide maleate is a piperazine derivative that acts as a weak calcium channel blocker and has been shown to reduce disability following acute ischemic stroke [7].